BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17827836)

  • 1. Asian variant of intravascular lymphoma: aspects of diagnosis and the role of rituximab.
    Shimizu I; Ichikawa N; Yotsumoto M; Sumi M; Ueno M; Kobayashi H
    Intern Med; 2007; 46(17):1381-6. PubMed ID: 17827836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Asian variant of intravascular large B-cell lymphoma diagnosed by bone marrow biopsy].
    Tadokoro J; Arai Y; Tokita K; Iso H; Nakamura Y; Maki K; Sasaki K; Mitani K
    Rinsho Ketsueki; 2007 Jan; 48(1):61-3. PubMed ID: 17313078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravascular large B-cell lymphoma: remission after rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy.
    Horváth B; Demeter J; Eros N; Hársing J; Csomor J; Matolcsy A; Bottlik G; Gyori G; Marschalkó M; Kárpáti S
    J Am Acad Dermatol; 2009 Nov; 61(5):885-8. PubMed ID: 19632742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary central nervous system involvement in 599 patients with diffuse large B-cell lymphoma: are there any changes in the rituximab era?
    Deng L; Song Y; Zhu J; Zheng W; Wang X; Xie Y; Lin N; Tu M; Ping L; Ying Z; Liu W; Zhang C
    Int J Hematol; 2013 Dec; 98(6):664-71. PubMed ID: 24234713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-vascular large B-cell lymphoma revealed by a nephrotic syndrome: a one year remission induced by a high frequency CHOP and rituximab.
    Girard T; Nochy D; Montravers F; Der Sahakian G; Fior R; Galanaud P; Boué F
    Leuk Lymphoma; 2004 Aug; 45(8):1703-5. PubMed ID: 15370230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
    Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab (MabThera) for aggressive non-Hodgkin's lymphoma: systematic review and economic evaluation.
    Knight C; Hind D; Brewer N; Abbott V
    Health Technol Assess; 2004 Sep; 8(37):iii, ix-xi, 1-82. PubMed ID: 15361313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab.
    Tai WM; Chung J; Tang PL; Koo YX; Hou X; Tay KW; Quek R; Tao M; Lim ST
    Ann Hematol; 2011 Jul; 90(7):809-18. PubMed ID: 21229246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.
    Shimada K; Yamaguchi M; Atsuta Y; Matsue K; Sato K; Kusumoto S; Nagai H; Takizawa J; Fukuhara N; Nagafuji K; Miyazaki K; Ohtsuka E; Okamoto M; Sugita Y; Uchida T; Kayukawa S; Wake A; Ennishi D; Kondo Y; Izumi T; Kin Y; Tsukasaki K; Hashimoto D; Yuge M; Yanagisawa A; Kuwatsuka Y; Shimada S; Masaki Y; Niitsu N; Kiyoi H; Suzuki R; Tokunaga T; Nakamura S; Kinoshita T
    Lancet Oncol; 2020 Apr; 21(4):593-602. PubMed ID: 32171071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factors in 41 consecutive Asian patients.
    Tai WM; Quah D; Yap SP; Tan SH; Tang T; Tay KW; Koo YX; Tao M; Quek R; Lim ST
    Leuk Lymphoma; 2011 Apr; 52(4):604-12. PubMed ID: 21261504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravascular large B-cell lymphoma presenting as multiple stroke: A case report.
    Yunce M; Muganlinskaya N; Selinger S
    Medicine (Baltimore); 2018 Oct; 97(41):e12793. PubMed ID: 30313105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravascular large B-cell lymphoma of the skin: typical clinical manifestations and a favourable response to rituximab-containing therapy.
    Feldmann R; Schierl M; Sittenthaler M; Jahn R; Wogritsch C; Cerroni L; Steiner A; Breier F
    Dermatology; 2009; 219(4):344-6. PubMed ID: 19590171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravascular large B-cell lymphoma diagnosed by total hysterectomy].
    Ogawa MA; Ieda M; Hayakawa M; Mizutani H; Ogawa K; Sato T; Satake T; Kojima Y
    Rinsho Ketsueki; 2022; 63(3):182-188. PubMed ID: 35387930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy.
    Villa D; Connors JM; Shenkier TN; Gascoyne RD; Sehn LH; Savage KJ
    Ann Oncol; 2010 May; 21(5):1046-52. PubMed ID: 19861575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravascular large B-cell lymphoma--a diagnostic dilemma.
    Ramkumar B; Hutchison R; Khadim H; Gajra A
    Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):e18-21. PubMed ID: 24060286
    [No Abstract]   [Full Text] [Related]  

  • 16. Random skin biopsy and bone marrow biopsy for diagnosis of intravascular large B cell lymphoma.
    Matsue K; Asada N; Odawara J; Aoki T; Kimura S; Iwama K; Fujiwara H; Yamakura M; Takeuchi M
    Ann Hematol; 2011 Apr; 90(4):417-21. PubMed ID: 20957365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab.
    Feugier P; Virion JM; Tilly H; Haioun C; Marit G; Macro M; Bordessoule D; Recher C; Blanc M; Molina T; Lederlin P; Coiffier B
    Ann Oncol; 2004 Jan; 15(1):129-33. PubMed ID: 14679132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asian variant of intravascular large B-cell lymphoma: a comparison of clinical features based on involvement of the central nervous system.
    Yoon SE; Kim WS; Kim SJ
    Korean J Intern Med; 2020 Jul; 35(4):946-956. PubMed ID: 31752477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of diffuse large B-cell lymphoma following Waldenström's macroglobulinemia with CHOP chemotherapy followed by combination therapy of CHOP with rituximab.
    Uchino K; Sameshima H; Miyamoto T; Iino T; Kato K; Henzan H; Aoki K; Nagafuji K; Gondo H; Harada M
    Intern Med; 2004 Feb; 43(2):131-4. PubMed ID: 15005256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.